WHO ICTRP trial
Persantin Preceding PCI
NL-OMON31171 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON31171 |
|---|---|
| Public title | Persantin Preceding PCI |
| Scientific title | Persantin Preceding PCI - P3 |
| Primary sponsor | Universitair Medisch Centrum Sint Radboud |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | heart infarction ischemia-reperfusion injury;10011082;heart infarction;ischemia-reperfusion injury |
| Interventions | pretreatment with Persantin Retard, 2dd 200mg or placebo. ;dipyridamole;elective PCI;ischemia-reperfusion injury |
| Registration date | Jul 1, 2008 |
| Target size | 250 |
| Secondary IDs | 2007-004620-20;NL18470.091.07 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: